Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-23-027586

Director acquired 2,533 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
STARR CHRISTOPHER M Director 2023-09-30 Option exercise +2,533 23,330 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
STARR CHRISTOPHER M Director 2023-09-30 Option exercise · Restricted Stock Units −2,533 2,533 D: show line 2 in the form
Loading xslF345X05/rdgdoc.xml…